In the present study, JQ1 also significantly inhibited Mmp13, Clec5a, and Gpr84 expression (Fig. 3E–G), and these inhibitory effects of JQ1 may play a potential role in immune disorder treatment, possibly through inhibition of macrophages and the ensuing inflammatory responses. The gene discussed is CLEC5A; the disease is immune system disorder.